Nature India Annual Volume 2020 is out

 

Cover image: S. Priyadarshini/ Design: Bharat Bhushan Upadhyay

2020 was defined by the global pandemic. Throughout the long, difficult year, disease and death came in tragic waves, testing the limits of healthcare systems, especially in countries with limited resources. In India, one of the worst affected countries, significant outbreaks continue in 2021.

A positive outcome, however, has been the triumph of science. In record time, scientists rushed to sequence the genome of the virus and its variants, created affordable diagnostic and treatment solutions, and produced multiple vaccine and drug candidates to control the pandemic. We have been covering the pandemic in India and the subcontinent in depth through the lens of science. Besides our regular journalistic coverage, we produced two special issues on the COVID-19 crisis in India – one on how the pandemic was affecting life in a country of 1.3 billion people, and the other on affordable engineering solutions being developed in haste by India’s scientists to confront the virus. In our quest for disseminating trusted information during a global public health emergency, the pages of Nature India were prominently filled with information on SARS-CoV-2 and COVID-19.

Meanwhile, despite challenges thrown up by a series of lockdowns and funding issues, science in other disciplines unrelated to the pandemic has continued to flourish. One criticism of scholarly science publishers and science magazines has been that their overwhelming engagement with the pandemic (public health, medicine, virology and epidemiology) has squeezed out other disciplines of science during 2020. In this annual volume, therefore, we are spotlighting Nature India’s coverage of all sciences, efforts around which quietly continued through 2020.

The biodiverse Himalayan region, straddling the borders of many countries in Asia, including India and China, offers immense potential for collaborative scientific research. However, the inhospitable terrain and geopolitical strife in the region, have created obstacles to a joined-up research climate. Our cover story tells of the growing call by researchers in the two countries to go beyond political differences and make the Himalayan region a hub for scientific collaborations. Migratory birds from across the region coming into India and the need for heronries to protect them are also highlighted in this issue.

The country is weighing the challenges and opportunities of an ambitious ‘one nation one subscription’ policy that aims to make scholarly knowledge freely accessible to everyone in the country. We analyse the merits of this proposed plan.

The pandemic is never far from the immediate consciousness of any of the world’s people, and our annual photo competition on the theme brought inspired images of this era, where masks, sanitation, immunisation, and innovative solutions to health needs are paramount, and the focus of our daily lives

The issue is free to download here. We will soon make all our previous annual volumes free to access.

You will find more on our archival annual issues here: 2019201820172016, 20152014 and 2007-2013.

We hope you enjoy reading the latest volume.

My science failures: How to err wisely

Science stories are equal to success stories. Right? Wrong. In thinking of scientists as successful people, we often assume that their career paths are straightforward, meticulously planned, and yield positive outcomes. However, things don’t always go as planned. Behind every small success, there’s probably a string of failures — work that did not make it to the curriculum vitae, rejected papers, turned-down applications, declined grants, unsuccessful job interviews, and many closed doors.

Science blooms in these failures as much as it does in the glory of accepted manuscripts, grants, awards, and patents. In this blog series “My Science Failures” we will hear some straight-from-the-heart stories of these secret milestones in the lives of scientists — and learn how they turned these events on their head (or did not).

Vijay Soni, an instructor at Weill Cornell Medicine, New York, says the actual reason why science is so successful is these failures.

Vijay Soni

In science, we fail more often and at a rate higher than in other vocations. Hypotheses go wrong, experiments do not deliver the expected outcomes. There are contaminations, misleadingly simplistic or representative models, false-positive results, experiments without controls, rejections of manuscripts, and failed projects. The actual reason, why science is so successful, is all these failures. It is, therefore, imperative to learn the real value of mistakes.

Failures are a sign that you are inventing,” says Elon Musk. Curiosity guides us to learn better and faster. We have been taught to attach connotations to words and are accustomed to believing that success is positive, and failures are negative. However, learnings are never black and white – they are a full rainbow. Each colour is an experience that must be enjoyed, lived, and felt.

Scientists hardly speak of false starts. There is nothing glamorous about dead and failed stories. And so there is a big chunk of knowledge that goes unreported or unpublished.

How do scientists cope with recurrent failures and grow? In my own research journey, many times I wish I knew about earlier false starts so that it didn’t have to go down an already failed path. I did not find any resource where scientists shared their wisdom from failures. Therefore, I started FailWise to offer learnings, information, opinion, and guidance around such failures. The inspiration came from Brandon Mull’s words: “Smart people learn from their mistakes, but the real sharp ones learn from the mistakes of others.”

Every scientist has a personal relationship with failures, and evolves uniquely. I have too. As a biology undergraduate, I learnt a big lesson early on when my lecturer published under his name all data from a research project I was working on to get a grant. Similarly, a lab mate presented my data without my consent or acknowledgment to get a postdoc position. Lesson I learnt: don’t disclose all your data and research to anyone. Never circulate your lab reports or critical data even among close friends.

There are more things that I learnt as a researcher:

  1. I studied undergraduate in a Hindi medium. I always felt it would be a problem when I go for higher studies. But I was wrong. Language is not a barrier in science but lack of knowledge is. I never stopped reading books and research articles. If you do not read background literature, maintain notes or connect the dots to frame your questions, you will likely fail. Learn to ask better questions, you will automatically be guided towards better answers.
  2. Once I was told that I would not have been hired if I was not from a certain lab (my master’s and undergraduate studies were from a very small state university in India). It was discouraging. But I reminded myself that people who follow their path passionately and honestly make great scientists and labs, and they may not necessarily be working in a world-class institute. No matter what your background, chase your dreams with perseverance.
  3. After Masters, I was working as a project assistant at a renowned institute in India. I was treated like a labourer there — never allowed to ask any question, asked to help in my principal investigator’s household work. He used foul language, forced me to work at least 12 hours every day, even on weekends. I tried hard to stay but gave up after 6 months and joined another lab. The lesson I learnt: Quit (as soon as possible) if you are not respected or treated properly. A mentor who does not provoke thought or gives you the freedom to ask questions, will likely not aid your career much. Choose your research mentor wisely. You can not do science when you have a micro-manager or a bad human for a mentor.
  4. During my undergraduate, I was selected for a presentation for a national-level scholarship. I researched hard for a project on neural tube defects and but I was not well prepared for the presentation. And thus I failed to get the scholarship. Lesson learnt: Bad communication or presentation skills will dampen your science. Work on them, ask for feedback from your mentor and lab mates. Do mock presentations, write notes, try recording and listening to them to improve your sentences and script.
  5. While I was doing Ph.D. I never explored anything beyond my lab. But during postdoc, I started attending various courses on entrepreneurship and leadership skills. This helped me start my own company (Scipreneur). Researchers seldom explore things beyond their labs. Remember, your network is your net worth. Try to participate in courses, meetings, competitions, and networking events. Use social media wisely and to your benefit. Read biographies, listen and watch good talks and podcasts. They will help you in multiple ways. Like how to manage stress and time, how to cope with failures, how to deal with relationship hurdles, and how to envision your future with a better goal? Do more informational interviews, where you ask an expert’s time to discuss how they achieved their goals.
  6. Entrepreneurship was always on my mind but I never explored it as I felt I lacked the skills required. I failed to start on some interesting ideas and later found that someone had worked on them successfully. It took me 6 to 7 years to realise that Ph.D. and postdoc leverage us with so many traits like leadership, mentoring, communication, negotiation, perseverance, collaboration, and entrepreneurial skills. Do not undervalue yourself. Learn to swim beyond your safe zone and against the currents. It will not only boost your confidence but also enhance your ability to cope with challenges.
  7. I have seen researchers working day and night but failing to achieve big. Donkey work will seldom give you great science and big breaks; smart work will. You need to polish your ideas, questions, plans and execution. Teamwork is dream work, so never hesitate to ask for help. Collaborate and discuss with peers. I also learnt to use technology in the right way to accelerate the pace of research and increase efficiency. For example, use software and languages for better and fast analysis, LinkedIn for better collaboration and learning, Evernote for writing and as a virtual notebook, simple web-based software for colony counting and standard curve plotting, and different online tools to make beautiful figures and presentations.

We cannot predict failure, but we should keep the lessons learnt imprinted in our minds. Collaborative learning and sharing help us see mistakes more positively. Failures can rewire our brains and give us the confidence to approach problems from a different angle. They force us to question our hypotheses, plans, protocols, execution, and experimental setups. The greatest thing a scientist can discover is “a novel or better question”. Give yourself permission to fail and explore.

Genetic sequencing tools key to pandemic fight

Indian-born British chemist Shankar Balasubramanian recently won the Millennium Technology Prize, instituted by the Technology Academy Finland, for development of revolutionary DNA sequencing techniques. Vanita Srivastava caught up with him to understand the award winning genetic sequencing work that has widely impacted the fields of genomics, medicine and biology.

[Shankar Balasubramanian is a Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, a Senior Group Leader at the Cancer Research UK Cambridge Institute and a Fellow of Trinity College, Cambridge. He won the one million euro prize jointly with David Klenerman.]

Shankar Balasubramanian{credit}University of Cambridge{/credit}

Q. Tell us about your genome sequencing technology and how it has impacted the course of the COVID-19 pandemic.

A. Prof David Klenerman and I are co-inventors of Solexa-Illumina Next Generation DNA Sequencing (NGS). The technology was fully developed at Solexa into an integrated, commercial system, then further improved by the team in Illumina. This technology has enabled fast, accurate, low-cost and large-scale genome sequencing, which is the process of determining the complete DNA sequence of an organism’s make-up.

During the pandemic, NGS has been providing an effective way to study SARS-CoV-2’s genetic make-up and help us track the viral mutations, which continues to be a great global concern. This work has also helped the creation of multiple vaccines now being administered worldwide and is critical to the creation of new vaccines against new dangerous viral strains.

Q. India is now a hotspot of coronavirus mutants. How can this technology help address problems relating to this?

A. By studying and understanding the genetic make-up of the new mutant using our technology, we can identify its potential as a new threat by knowing how it differs from the other variants. Further, I hope that our technology can be useful in sequencing the genomes of people who have had COVID and trying to get an understanding of why some people are severely affected by the disease and others are asymptomatic. This approach could identify risk factors in specific people that may also be applicable to other viruses in years to come.

Q. What other potential use does this technology have?

A. The technology has a huge transformative impact in the fields of genomics, medicine and biology. It is being applied widely in the basic research of living systems, as DNA and RNA are fundamental to cells and organisms. Aspects of living systems include genetics, the expression of genes, the structure of DNA in the nucleus and differences between cells, to name but a few.

The technology is beginning to be applied in medicine, particularly in the areas of cancer and rare diseases. The applications in medicine will grow as we sequence more human genomes allowing the idea of personalised medicine where diseases are more optimally treated by understanding the individual and the drugs that are used are designed to correct the molecular pathway that has gone in a specific person. It will also be used in agriculture to breed species with desired properties.

Over the past few years, there have been tremendous advances in cancer, both with therapy and also detection and diagnosis. Over the coming decades, the goal is to use this technology to help make some cancers become manageable diseases because they are detected sufficiently early and it’s clear what has to be done. This could also hopefully be extended to other complex diseases such as heart disease and Alzheimer’s disease.

Q. What are the challenges to personalised genomic medicine?

A. Developing an effective and efficient infrastructure for sequencing patients on a large scale and using their genetic profile to help make the decisions in regard to the prevention, diagnosis, and treatment of their disease is currently the biggest challenge.